Race/ethnicity and disease severity in IGA nephropathy.

被引:0
|
作者
Hall, YN
Fuentes, EF
Chertow, GM
Olson, JL
机构
[1] Univ Calif San Francisco, Div Nephrol, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:748A / 748A
页数:1
相关论文
共 50 条
  • [41] Urinary TGF beta 1, better than IL-6, reflects clinical and pathological severity of IgA nephropathy.
    Yoshida, H
    Machiguchi, T
    Tamura, T
    Yonemoto, S
    Fukushima, H
    Minakata, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2093 - A2093
  • [42] A randomized control study of mycophenolate mofetil treatment in severe IgA nephropathy.
    Chen, XM
    Chen, P
    Cai, GY
    Wu, J
    Cui, Y
    Zhang, YP
    Liu, SW
    Li, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 14A - 14A
  • [43] The angiotensinogen gene M235T polymorphism and IgA nephropathy.
    Schmidt, S
    Bahnisch, J
    Campise, M
    Clarkson, A
    Ferrario, F
    Ponticelli, C
    Ritz, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3083 - A3083
  • [44] Effects of steroid therapy on interstitial fibrosis of the kidney in advanced IgA nephropathy.
    Kushiyama, T
    Owada, K
    Sakurai, K
    Kuriki, M
    Eiro, M
    Asahi, K
    Katoh, T
    Watanabe, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 754A - 754A
  • [45] Influence of interleukin-10 genetic polymorphisms on the progression of IgA nephropathy.
    Bantis, C
    Heering, PJ
    Klein-Vehne, N
    Grabensee, B
    Ivens, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 129A - 129A
  • [46] PROTEINURIA AND PROGRESSION OF IGA NEPHROPATHY. HAVE WE REACHED THE POINT OF NO RETURN?
    Movilla Echeverri, Carolina Isabel
    Andrades Gomez, Cristina
    Naranjo Arellano, Macarena
    Alarcon Garcelan, Carmen
    Cazalla Cardenas, Fatima
    Lopez Mendoza, Virginia Cabello Chaves Manuel
    Gomez Counago, Inmaculada
    Batalha, Paula
    Perez Valdivia, Miguel Angel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I316 - I316
  • [47] Localization of hepatocyte growth factor (HGF) and tubulointerstitial lesions in IgA nephropathy.
    Taniguchi, Y
    Yamashita, K
    Yorioka, N
    Masaki, T
    Ogawa, T
    Yamakido, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0493 - A0493
  • [48] Combined treatment of prednisolone and angiotensin II receptor blocker in IgA nephropathy.
    Ihm, CG
    Lee, SH
    Lee, SH
    Kim, YH
    Lee, T
    Kim, MJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 752A - 752A
  • [49] High-dose intravenous immunoglobulin therapy for progressive IgA nephropathy.
    Lukas, R
    Keller, F
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1997, 26 (08) : 362 - 365
  • [50] Increased systemic-homing T cell numbers in IgA nephropathy.
    Batra, A
    Foster, EM
    Barratt, J
    Montgomery, U
    Feehally, J
    Smith, AC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 350A - 350A